Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating metabolic adaptation to weight loss in adolescents with obesity, comparing a behavioral lifestyle program with and without s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wegovy (semaglutide) (semaglutide)

Snippet

Sponsor: McMaster University | Conditions: Obesity (Disorder) | Phase 4 | Status: RECRUITING